meta-analysis | Q815382 |
scholarly article | Q13442814 |
P50 | author | Olli Raitakari | Q23039996 |
Peter Vollenweider | Q28039313 | ||
Florian Kronenberg | Q28039325 | ||
Claudia Lamina | Q28050004 | ||
Mika Kähönen | Q29839349 | ||
Terho Lehtimäki | Q29839397 | ||
Gérard Waeber | Q29839423 | ||
Annette Peters | Q37629853 | ||
Stefan Coassin | Q42643471 | ||
Ilkka Seppälä | Q47157531 | ||
Sven Bergmann | Q55590536 | ||
Konstantin Strauch | Q76510167 | ||
Rico Rueedi | Q84253992 | ||
Steven C Hunt | Q89298880 | ||
P2093 | author name string | Christian Gieger | |
Thomas Meitinger | |||
Bernhard Paulweber | |||
Pedro Marques-Vidal | |||
Gertraud Erhart | |||
Lukas Forer | |||
Sebastian Schönherr | |||
Janina S Ried | |||
Noha A Yousri | |||
Ludmilla Kedenko | |||
Andrea Stöckl | |||
Doreen Dähnhardt | |||
Salome Mack | |||
KORA-Study Group | |||
P2860 | cites work | Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project | Q21061203 |
A genome-wide association study identifies protein quantitative trait loci (pQTLs) | Q21145048 | ||
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma | Q24561687 | ||
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production | Q24601964 | ||
A method and server for predicting damaging missense mutations | Q27860835 | ||
Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians | Q28144283 | ||
Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians | Q28210260 | ||
Apolipoprotein E isoforms and lipoprotein metabolism | Q28249988 | ||
A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease | Q28267020 | ||
ORegAnno 3.0: a community-driven resource for curated regulatory annotation | Q28269966 | ||
Meta-analysis of 49 549 individuals imputed with the 1000 Genomes Project reveals an exonic damaging variant in ANGPTL4 determining fasting TG levels | Q28596453 | ||
GATES: a rapid and powerful gene-based association test using extended Simes procedure | Q28741872 | ||
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q | Q30486850 | ||
A knowledge-based weighting framework to boost the power of genome-wide association studies | Q33789144 | ||
LPA and PLG sequence variation and kringle IV-2 copy number in two populations | Q33818108 | ||
Distribution and medical impact of loss-of-function variants in the Finnish founder population | Q33981677 | ||
Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis | Q34265255 | ||
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress | Q34346809 | ||
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis | Q34473809 | ||
Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans | Q34475541 | ||
Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study | Q35020898 | ||
Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies | Q35136958 | ||
Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations | Q35230992 | ||
Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. | Q35234069 | ||
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations | Q35603379 | ||
Genomic heritability: what is it? | Q35622494 | ||
Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes | Q35721709 | ||
The impact of low-frequency and rare variants on lipid levels | Q36591109 | ||
Sex-Specific Genetic Variants are Associated With Coronary Endothelial Dysfunction | Q36877201 | ||
Inflammation stimulates the expression of PCSK9 | Q36945328 | ||
Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study | Q37170991 | ||
Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts | Q37678895 | ||
Lipoprotein(a): resurrected by genetics | Q38045424 | ||
TLR2 and TLR4 in autoimmune diseases: a comprehensive review | Q38172423 | ||
Hyperlipoproteinemia type 3: the forgotten phenotype | Q38235600 | ||
Structure, function, and genetics of lipoprotein (a). | Q38807488 | ||
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels | Q39071274 | ||
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials | Q39354204 | ||
SNiPA: an interactive, genetic variant-centered annotation browser | Q39520922 | ||
Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians | Q39900228 | ||
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man | Q40108225 | ||
A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction. | Q40227515 | ||
Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene | Q42447270 | ||
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration | Q42600872 | ||
Parental history and myocardial infarction risk across the world: the INTERHEART Study | Q43551638 | ||
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction | Q44238417 | ||
LPA Gene, Ethnicity, and Cardiovascular Events | Q46076964 | ||
The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles | Q46171048 | ||
A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a). | Q46221191 | ||
Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients | Q46239308 | ||
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. | Q50572117 | ||
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study. | Q53789135 | ||
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk. | Q54203344 | ||
Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random | Q57811672 | ||
To stratify or not to stratify: power considerations for population-based genome-wide association studies of quantitative traits | Q60585330 | ||
Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism | Q72404804 | ||
Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo E | Q72428827 | ||
The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration | Q73307877 | ||
Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene | Q78663526 | ||
Lipoprotein(a)-cholesterol: a significant component of serum cholesterol | Q84358732 | ||
Genetic determination of lipoprotein(a) and its association with cardiovascular disease: convenient does not always mean better | Q87160159 | ||
P433 | issue | 9 | |
P921 | main subject | genome-wide association study | Q1098876 |
LPA | Q18028636 | ||
P304 | page(s) | 1834-1844 | |
P577 | publication date | 2017-05-16 | |
P1433 | published in | Journal of Lipid Research | Q6295449 |
P1476 | title | A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms | |
P478 | volume | 58 |
Q58566313 | A comprehensive map of single base polymorphisms in the hypervariable LPA Kringle IV-2 copy number variation region |
Q94445741 | A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter |
Q89934238 | Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis |
Q91693987 | Carotid Intima-Media Thickness: Novel Loci, Sex-Specific Effects, and Genetic Correlations With Obesity and Glucometabolic Traits in UK Biobank |
Q93086121 | Cohort profile: role of lipoproteins in cardiovascular disease-the LipidCardio study |
Q55427348 | Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries. |
Q90269588 | Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis |
Q52641914 | Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in Finns. |
Q58123851 | Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin |
Q87799091 | Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study |
Q47274864 | Lipoprotein(a) in clinical practice: New perspectives from basic and translational science |
Q88497342 | Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease |
Q108126970 | Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank |
Q52691298 | Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content. |
Search more.